The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kaprin A.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Bojko A.V.

GBOU VPO «Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet» Minzdrava Rossii, Tomsk

Gevorkov A.R.

P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russian Federation

Bolotina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

The current state of radiotherapy in patients with oropharyngeal squamous cell carcinoma. A radiation therapist’s view

Authors:

Kaprin A.D., Bojko A.V., Gevorkov A.R., Bolotina L.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2017;6(4): 4‑8

DOI: 10.17116/onkolog2017644-8

Read: 3444 times

Download PDF (RU)
Contact the author
Table of contents

THE CURRENT STATE OF RADIOTHERAPY IN PATIENTS WITH OROPHARYNGEAL SQUAMOUS CELL CARCINOMA. A RADIATION THERAPIST’S VIEW
THE CURRENT STATE OF RADIOTHERAPY IN PATIENTS WITH OROPHARYNGEAL SQUAMOUS CELL CARCINOMA. A RADIATION THERAPIST’S VIEW

To cite this article:

Kaprin AD, Bojko AV, Gevorkov AR, Bolotina LV. The current state of radiotherapy in patients with oropharyngeal squamous cell carcinoma. A radiation therapist’s view. P.A. Herzen Journal of Oncology. 2017;6(4):4‑8. (In Russ.)
https://doi.org/10.17116/onkolog2017644-8

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Neoadjuvant drug therapy and onco­logical outcomes in patients with stage I–II breast cancer. P.A. Herzen Journal of Onco­logy. 2025;(1):5-12
The choice of radiotherapy dose fractionation regi­men for grade 4 gliomas depe­nding on the status of MGMT. P.A. Herzen Journal of Onco­logy. 2025;(1):13-18
Soli­tary fibrous tumor of the oropharynx. P.A. Herzen Journal of Onco­logy. 2025;(1):48-52
Features of the clinical course of biological subtypes of squamous cell oropharyngeal carcinoma. P.A. Herzen Journal of Onco­logy. 2025;(1):58-62
Clinical effi­cacy of high-intensity magnetic therapy and transcutaneous electrical nerve stimulation in patients with diabetes mellitus and distal poly­neuropathy: a randomized study. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(1):5-11
Effi­cacy and safety of mome­tasone and olopatadine combination for nasal use in patients with alle­rgic rhinitis caused by sensitization to epidermal alle­rgens in continuous expo­sure. Russian Rhinology. 2025;(1):48-56
Surgical treatment of nasal liquorea in patients with posttraumatic defect of posterior wall of the frontal sinus. Russian Rhinology. 2025;(1):65-71
Treatment of acute hemo­rrhoids acco­rding to the resu­lts of a multicenter obse­rvational study. Piro­gov Russian Journal of Surgery. 2025;(3):112-123
Diagnosis and treatment of three synchronous early squamous cell carcinomas of the esophagus: case report. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):104-110
Vali­dation of the Russian version of the Caro­linas Comfort Scale in patients after previous abdo­minal hernia repair with mesh. Piro­gov Russian Journal of Surgery. 2025;(4):30-30
Abstract:

The paper presents major trends in the treatment of patients with oropharyngeal squamous cell carcinoma. Special attention is paid to the current possibilities of radiation therapy and its combination with drug therapy (chemotherapy, targeted therapy). The paper also deals with the issues of an individual approach to choosing the policy of treatment based on the predictors of its efficiency. Preserving the quality of life in patients is considered to be one of the main tasks and adequate accompanying therapy is deemed to be a mandatory condition for the success of anticancer treatment and rehabilitation of patients.

Keywords:

squamous cell carcinoma
head and neck tumors
radiotherapy
chemoradiotherapy
targeted modification
combined treatment
quality of life
accompanying therapy

Authors:

Kaprin A.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Bojko A.V.

GBOU VPO «Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet» Minzdrava Rossii, Tomsk

Gevorkov A.R.

P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russian Federation

Bolotina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Close metadata

References:

  1. The Global Burden of Cancer 2013. Global Burden of Disease Cancer Collaboration. JAMA Oncol. 2015;1(4):505-527. https://doi.org/10.1001/jamaoncol.2015.0735
  2. Bernier J, ed. Head and neck cancer. Multimodality management. Springer; 2016. https://doi.org/10.1007/978-3-319-27601-4
  3. Kaprin AD, Starinskii VV, Petrova GV, eds. The state of cancer care in Russia 2015 [Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2015]. Moscow: MNIOI im. P.A. Gertsena — filial FGBU «NMIRTs» Minzdrava Rossii; 2016. (In Russ.).
  4. Hansen EK, Roach M. Handbook of evidence-based radiation oncology. 2nd ed. Springer; 2010. (In Russ.).
  5. Lu JJ, Brady LW. Radiation oncology an evidence-based approach. Berlin, Heidelberg: Springer-Verlag; 2008. https://doi.org/10.1007/978-3-540-77385-6
  6. Pignon JP, Maitre AL, Maillard E, Bourhis J. On behalf of the MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients. Radiother Oncol. 2009;92(1):4-14. https://doi.org/10.1016/j.radonc.2009.04.014
  7. Beyzadeoglu M, Ebruli C, Ozyigit G. Basic radiation oncology. Berlin, Heidelberg: Springer-Verlag; 2010. https://doi.org/10.1007/978-3-642-11666-7
  8. Adelstein DJ. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21(1):92-98. https://doi.org/10.1200/JCO.2003.01.008
  9. Rades D, Seidl D, Janssen S, et al. Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers. BMC Cancer. 2016;16:437. https://doi.org/10.1186/s12885-016-2478-8
  10. Hall SF, Griffiths R. Did the addition of concomitant chemotherapy to radiotherapy improve outcomes in hypopharyngeal cancer? A population-based study. Curr Oncol. 2016;23(4):266-272. https://doi.org/10.3747/co.23.3085
  11. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACHNC Collaborative Group. Lancet. 2000;355(9208):949-955.
  12. Bourhis J, Pignon JP, et al. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. In: Paper presented at American Society of Clinical Oncology (ASCO) annual meeting. 2004. https://doi.org/10.1016/j.radonc.2009.04.014
  13. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338(25):1798-1804. https://doi.org/10.1056/NEJM199806183382503
  14. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91(24):2081-2086.
  15. Posner MR, Le Lann L, et al. TAX 324: A phase III trial at TPF vs. PF induction chemotherapy followed chemoradiotherapy in locally advanced SCCHN. In: Paper presented at American Society of Clinical Oncology (ASCO) annual meeting. Atlanta GA; 2006.
  16. Calais G, Alfonsi M, et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. In: Paper presented at American Society of Clinical Oncology (ASCO) annual meeting. Atlanta GA; 2006.
  17. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for loco regionally advanced head and neck cancer: 5-year survival data from a phase 3 randomized trial and relation between cetuximab induced rash and survival. Lancet Oncol. 2010;11:21-28. https://doi.org/10.1016/S1470-2045(09)70311-0
  18. Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014;32(27):2940-2950. https://doi.org/10.1200/JCO.2013.53.5633
  19. Shah JP, Patel SG, Singh B, eds. Jatin Shah’s head and neck sugery and oncology. 4th ed. Elsevier Mosby; 2012.
  20. Kiseleva ES, ed. Malignant tumor radiotherapy. Clinical guide [Luchevaya terapiya zlokachestvennykh opukholei. Rukovodstvo dlya vrachei]. Moscow: Meditsina; 1996. (In Russ.).
  21. Pivot X, Felip E. ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(2):79-80.
  22. Videtic GMM. Handbook of treatment planning in radiation oncology. Demos Med Publ.; 2015.
  23. Polyakov PYu. Tissue radiosensivity correction possibilities in clinical oncology. Dis. Obninsk; 2009. Accessed 22.05.2017. Available at: http://www.dissercat.com/content/voz-mozhnosti-upravleniya-tkanevoi-radiochuvstvitelnostyu-v-klinicheskoi-onkologii (In Russ.).
  24. McCoul ED, Har-El G. Meta-analysis of impaired vocal cord mobility as prognostic factor in t2 glottic carcinoma. Arch Otolaryngol Head Neck Surg. 2009;135(5):479-486. https://doi.org/10.1001/archoto.2009.47
  25. Scully C, Bagan JV. Recent advances in oral oncology 2007: imaging, treatment and treatment outcomes. Oral Oncol. 2008;44:211-215. https://doi.org/10.1016/j.oraloncology.2008.01.006
  26. Ryu C-H, Roh JL, Kim SB, Lee SW, Choi SH, et al. Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma. Ann Oncol. 2013;24:1049-1064. https://doi.org/10.1093/annonc/mds540
  27. Argiris A, Brockstein BE, Haraf DJ, et al. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res. 2004;10:1956-1962. https://doi.org/10.1158/1078-0432.CCR-03-1077
  28. Kang HS, Roh JL, Lee S, et al. Noncancer-related health events and mortality in head and neck cancer patients after definitive radiotherapy. A Prospective Study. Medicine (Baltimore). 2016;95(19):e3403. https://doi.org/10.1097/MD.0000000000003403
  29. Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG, et al. NCCN Task Force Report. Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw. 2008;6(Suppl.1):S1-21.
  30. Rosenthal DI, Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol. 2009;19:29-34. https://doi.org/10.1016/j.semradonc.2008.09.006
  31. Campos MI, Campos CN, Aarestrup FM, Aarestrup BJ. Oral mucositis in cancer treatment: natural history, prevention and treatment. Mol Clin Oncol. 2014;2:337-340. https://doi.org/10.3892/mco.2014.253
  32. Zhu G. Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma. BMC Cancer. 2016;16:42. https://doi.org/10.1186/s12885-016-2073-z
  33. NCCN. NCCN Clinical Practice Guidelines in Oncology. Version 2. 2016. Web site. Available at: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp
  34. Vera-Llonch M. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106:329-336. https://doi.org/10.1002/cncr.21622
  35. Mortensen HR, Overgaard J, Jensen K, Specht L, Overgaard M, Johansen J, et al. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol. 2013;52(7):1535-1542. https://doi.org/10.3109/0284186X.2013.824609
  36. Mourad WF, Hu KS, Puckett L, et al. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. Am J Clin Oncol. 2014; 37:57-62. https://doi.org/10.1097/COC.0b013e31826b9920
  37. Prevost V, Joubert C, Heutte N, Babin E. Assessment of nutritional status and quality of life in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:112-120. https://doi.org/10.1016/j.anorl.2013.06.007
  38. Gorbunova VA, Breder VV. Oncologic patient’s quality of life. In: 4th Russian oncologic conference [Materialy 4 Rossiiskoi onkologicheskoi konferentsii]. Moscow, 21—23 November 2000. Moscow; 2000:125-127. (In Russ.).
  39. Husaini H, Lazarus C, Hu K, et al. EORTC QOL rating, performance status, and oral outcomes in head-and-neck cancer patients treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2013;87:441-442.
  40. Kumari AC, Shanmughakumar S, Balasubramaniam P. Assessment of quality of life in head and neck cancer patients with enteral tube feeding. J Cancer Res Ther. 2012;8:176.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.